Goldman
R. Neuropsychological dysfunction and schizophrenia: implications for pharmacotherapy. Dir Psychiatry. 1998;1835- 47
Harvey
PD, Doherty
NM, Serper
MR, Rasmussen
M. Cognitive deficits and thought disorder, II: an 8-month followup study. Schizophr Bull. 1990;16147- 156
Kay
SR, Murrill
LM. Predicting outcome of schizophrenia: significance of symptom profiles and outcome dimensions. Compr Psychiatry. 1990;3191- 102
CrossRefGoldman-Rakic
PS. Working memory dysfunction in schizophrenia. J Neuropsychiatry Clin Neurosci. 1994;6348- 357
Carter
CS, Perlstein
W, Ganguli
R, Brar
J, Mintun
M, Cohen
JD. Functional hypofrontality and working memory dysfunction in schizophrenia. Am J Psychiatry. 1998;1551285- 1287
Stone
M, Gabrieli
JD, Stebbins
GT, Sullivan
EV. Working and strategic memory deficits in schizophrenia. Neuropsychology. 1998;12278- 288
CrossRefGold
JM, Carpenter
CJ, Randolph
C, Goldberg
T, Weinberger
DR. Auditory working memory and Wisconsin Card Sorting Test performance in schizophrenia. Arch Gen Psychiatry. 1997;54159- 165
CrossRefWeinberger
DR, Berman
KF. Prefrontal function in schizophrenia: confounds and controversies. Philos Trans R Soc Lond B Biol Sci. 1996;3511495- 1503
CrossRefStrous
RD, Cowan
N, Ritter
W, Javitt
DC. Auditory sensory ("echoic") memory dysfunction in schizophrenia. Am J Psychiatry. 1995;1521517- 1519
Holcomb
HH, Ritzl
EK, Medoff
DR, Nevitt
J, Gordon
B, Tamminga
CA. Tone discrimination performance in schizophrenic patients and normal volunteers: impact of stimulus presentation levels and frequency differences. Psychiatry Res. 1995;5775- 82
CrossRefWexler
BE, Stevens
AA, Bowers
AA, Sernyak
MJ, Goldman-Rakic
PS. Word and tone working memory deficits in schizophrenia. Arch Gen Psychiatry. 1998;551093- 1096
CrossRefJavitt
DC, Liederman
E, Cienfuegos
A, Shelley
AM. Panmodal processing imprecision as a basis for dysfunction of transient memory storage systems in schizophrenia. Schizophr Bull. 1999;25763- 775
CrossRefFleming
K, Goldberg
TE, Binks
S, Randolph
C, Gold
JM, Weinberger
DR. Visuospatial working memory in patients with schizophrenia. Biol Psychiatry. 1997;4143- 49
CrossRefServan-Schreiber
D, Cohen
JD, Steingard
S. Schizophrenic deficits in the processing of context: a test of a theoretical model. Arch Gen Psychiatry. 1996;531105- 1112
CrossRefCohen
JD, Barch
DM, Carter
C, Servan-Schreiber
D. Context-processing deficits in schizophrenia: converging evidence from three theoretically motivated cognitive tasks. J Abnorm Psychol. 1999;108120- 133
CrossRefCohen
JD, Servan-Schreiber
D. Context, cortex, and dopamine: a connectionist approach to behavior and biology in schizophrenia. Psychol Rev. 1992;9945- 77
CrossRefCohen
JD, Servan-Schreiber
D. A theory of dopamine function and its role in cognitive deficits in schizophrenia. Schizophr Bull. 1993;1985- 104
Naatanen
R. The mismatch negativity: a powerful tool for cognitive neuroscience. Ear Hear. 1995;166- 18
CrossRefRitter
W, Deacon
D, Gomes
H, Javitt
DC, Vaughan
HG
Jr. The mismatch negativity of event-related potentials as a probe of transient auditory memory: a review. Ear Hear. 1995;1652- 67
CrossRefShelley
AM, Ward
PB, Catts
SV, Michie
PT, Andrews
S, McConaghy
N. Mismatch negativity: an index of a preattentive processing deficit in schizophrenia. Biol Psychiatry. 1991;301059- 1062
CrossRefJavitt
DC, Doneshka
P, Zylberman
I, Ritter
W, Vaughan
HG
Jr. Impairment of early cortical processing in schizophrenia: an event-related potential confirmation study. Biol Psychiatry. 1993;33513- 519
CrossRefCatts
SV, Shelley
AM, Ward
PB, Liebert
B, McConaghy
N, Andrews
S, Michie
PT. Brain potential evidence for an auditory sensory memory deficit in schizophrenia. Am J Psychiatry. 1995;152213- 219
Javitt
DC, Doneshka
P, Grochowski
S, Ritter
W. Impaired mismatch negativity generation reflects widespread dysfunction of working memory in schizophrenia. Arch Gen Psychiatry. 1995;52550- 558
CrossRefJavitt
DC, Grochowski
S, Shelley
AM, Ritter
W. Impaired mismatch negativity (MMN) generation in schizophrenia as a function of stimulus deviance, probability, and interstimulus/interdeviant interval. Electroencephalogr Clin Neurophysiol. 1998;108143- 153
CrossRefAlain
C, Hargrave
R, Woods
DL. Processing of auditory stimuli during visual attention in patients with schizophrenia. Biol Psychiatry. 1998;441151- 1159
CrossRefKasai
K, Okazawa
K, Nakagome
K, Hiramatsu
K, Hata
A, Fukuda
M, Honda
M, Miyauchi
M, Matsushita
M. Mismatch negativity and N2b attenuation as an indicator for dysfunction of the preattentive and controlled processing for deviance detection in schizophrenia: a topographic event-related potential study. Schizophr Res. 1999;35141- 156
CrossRefKreitschmann-Andermahr
I, Rosburg
T, Meier
T, Volz
HP, Nowak
H, Sauer
H. Impaired sensory processing in male patients with schizophrenia: a magnetoencephalographic study of auditory mismatch detection. Schizophr Res. 1999;35121- 129
CrossRefHirayasu
Y, Potts
GF, O'Donnell
BF, Kwon
JS, Arakaki
H, Akdag
SJ, Levitt
JJ, Shenton
ME, McCarley
RW. Auditory mismatch negativity in schizophrenia: topographic evaluation with a high-density recording montage. Am J Psychiatry. 1998;1551281- 1284
O'Donnell
BF, Hokama
H, McCarley
RW, Smith
RS, Salisbury
DF, Mondrow
E, Nestor
PG, Shenton
ME. Auditory ERPs to non-target stimuli in schizophrenia: relationship to probability, task-demands, and target ERPs. Int J Psychophysiol. 1994;17219- 231
CrossRefKathmann
N, Wagner
M, Rendtorff
N, Engel
RR. Delayed peak latency of the mismatch negativity in schizophrenics and alcoholics. Biol Psychiatry. 1995;37754- 757
CrossRefJavitt
DC, Shelley
AM, Ritter
W. Associated deficits in mismatch negativity generation and tone matching in schizophrenia. Clin Neurophysiol. 2000;1111733- 1737
CrossRefJavitt
DC, Zukin
SR. Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry. 1991;1481301- 1308
Heresco-Levy
U, Javitt
DC. The role of
N-methyl-D-aspartate (NMDA) receptor-mediated neurotransmission in the pathophysiology and therapeutics of psychiatric syndromes. Eur Neuropsychopharmacol. 1998;8141- 152
CrossRefUmbricht
D, Schmid
L, Koller
R, Vollenweider
FX, Hell
D, Javitt
DC. Ketamine-induced deficits in auditory and visual context-dependent processing in healthy volunteers: implications for models of cognitive deficits in schizophrenia. Arch Gen Psychiatry. 2000;571139- 1147
CrossRefLieberman
JA, Alvir
JM, Woerner
M, Degreef
G, Bilder
RM, Ashtari
M, Bogerts
B, Mayerhoff
DI, Geisler
SH, Loebel
A. Prospective study of psychobiology in first-episode schizophrenia at Hillside Hospital. Schizophr Bull. 1992;18351- 371
Spitzer
RL, Williams
JBW, Gibbon
M, First
MB. Structured Clinical Interview for DSM-III-R. Washington, DC American Psychiatric Press1990;
Nestor
PG, Faux
SF, McCarley
RW, Penhune
V, Shenton
ME, Pollak
S, Sands
SF. Attentional cues in chronic schizophrenia: abnormal disengagement of attention. J Abnorm Psychol. 1992;101682- 689
CrossRefMcNicol
D. A Primer of Signal Detection Theory. London, England Allen & Unwin1972;
Chapman
LJ, Chapman
JP. The measurement of differential deficit. J Psychiatr Res. 1978;14303- 311
CrossRefOades
RD, Dittmann-Balcar
A, Zerbin
D, Grzella
I. Impaired attention-dependent augmentation of MMN in nonparanoid vs paranoid schizophrenic patients: a comparison with obsessive-compulsive disorder and healthy subjects. Biol Psychiatry. 1997;411196- 1210
CrossRefGiard
MH, Lavikainen
J, Reinikainen
K, Perrin
F, Bertrand
O, Thevenet
M, Pernier
J, Naatanen
R. Separate representation of stimulus frequency, intensity and duration in auditory sensory memory: an event-related potential and dipole model analysis. J Cogn Neurosci. 1995;7133- 143
CrossRefGoldman-Rakic
PS, Prefrontal cortical dysfunction in schizophrenia: the relevance of working memory. Carroll
BJ, Barrett
JE.eds.Psychopathology and the Brain New York, NY Raven Press1991;1- 24
Javitt
DC, Zukin
SR. The role of excitatory amino acids in neuropsychiatric illness. J Neuropsychiatry Clin Neurosci. 1990;244- 52
Olney
JW, Farber
NB. Glutamate receptor dysfunction in schizophrenia. Arch Gen Psychiatry. 1995;52998- 1007
CrossRefCoyle
JT. The glutamatergic dysfunction hypothesis for schizophrenia. Harv Rev Psychiatry. 1996;3241- 253
CrossRefCarlsson
A, Hansson
LO, Waters
N, Carlsson
ML. A glutamatergic deficiency model of schizophrenia. Br J Psychiatry Suppl. 1999;372- 6
Hirsch
SR, Das
I, Garey
LJ, de Belleroche
J. A pivotal role for glutamate in the pathogenesis of schizophrenia, and its cognitive dysfunction. Pharmacol Biochem Behav. 1997;56797- 802
CrossRefJavitt
DC. Negative schizophrenic symptomatology and the PCP (phencyclidine) model of schizophrenia. Hillside J Clin Psychiatry. 1987;912- 35
Abi-Saab
WM, D'Souza
DC, Moghaddam
B, Krystal
JH. The NMDA antagonist model for schizophrenia: promise and pitfalls. Pharmacopsychiatry. 1998;31(suppl 2)104- 109
CrossRefNewcomer
JW, Farber
NB, Jevtovic-Todorovic
V, Selke
G, Melson
AK, Hershey
T, Craft
S, Olney
JW. Ketamine-induced NMDA receptor hypofunction as a model of memory impairment and psychosis. Neuropsychopharmacology. 1999;20106- 118
CrossRef